DARWIN AG (7V0.DE) Fundamental Analysis & Valuation

FRA:7V0 • DE000A3C35W0

Current stock price

9.15 EUR
+0.3 (+3.39%)
Last:

This 7V0.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. 7V0.DE Profitability Analysis

1.1 Basic Checks

  • 7V0 had positive earnings in the past year.
7V0.DE Yearly Net Income VS EBIT VS OCF VS FCF7V0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

  • The Return On Assets of 7V0 (13.36%) is better than 87.50% of its industry peers.
  • With an excellent Return On Equity value of 17.51%, 7V0 belongs to the best of the industry, outperforming 90.28% of the companies in the same industry.
  • 7V0 has a better Return On Invested Capital (14.71%) than 91.67% of its industry peers.
Industry RankSector Rank
ROA 13.36%
ROE 17.51%
ROIC 14.71%
ROA(3y)10.66%
ROA(5y)N/A
ROE(3y)19.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
7V0.DE Yearly ROA, ROE, ROIC7V0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 20 30 40

1.3 Margins

  • The Profit Margin of 7V0 (71.56%) is better than 97.22% of its industry peers.
  • The Operating Margin of 7V0 (104.25%) is better than 98.61% of its industry peers.
  • 7V0 has a Gross Margin of 40.86%. This is comparable to the rest of the industry: 7V0 outperforms 47.22% of its industry peers.
Industry RankSector Rank
OM 104.25%
PM (TTM) 71.56%
GM 40.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
7V0.DE Yearly Profit, Operating, Gross Margins7V0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 7V0.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 7V0 is creating value.
  • 7V0 has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for 7V0 is higher compared to a year ago.
7V0.DE Yearly Shares Outstanding7V0.DE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
7V0.DE Yearly Total Debt VS Total Assets7V0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • 7V0 has an Altman-Z score of 4.43. This indicates that 7V0 is financially healthy and has little risk of bankruptcy at the moment.
  • 7V0 has a better Altman-Z score (4.43) than 70.83% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that 7V0 is not too dependend on debt financing.
  • The Debt to Equity ratio of 7V0 (0.06) is better than 65.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.43
ROIC/WACC1.94
WACC7.59%
7V0.DE Yearly LT Debt VS Equity VS FCF7V0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 9.48 indicates that 7V0 has no problem at all paying its short term obligations.
  • 7V0 has a Current ratio of 9.48. This is amongst the best in the industry. 7V0 outperforms 90.28% of its industry peers.
  • 7V0 has a Quick Ratio of 8.10. This indicates that 7V0 is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of 7V0 (8.10) is better than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 9.48
Quick Ratio 8.1
7V0.DE Yearly Current Assets VS Current Liabilites7V0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 7V0.DE Growth Analysis

3.1 Past

  • 7V0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45606.06%, which is quite impressive.
  • Looking at the last year, 7V0 shows a very strong growth in Revenue. The Revenue has grown by 39.21%.
EPS 1Y (TTM)45606.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)39.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 6.23% on average over the next years.
  • The Revenue is expected to grow by 50.48% on average over the next years. This is a very strong growth
EPS Next Y-81.25%
EPS Next 2Y-81.7%
EPS Next 3Y-24.02%
EPS Next 5Y6.23%
Revenue Next Year123.83%
Revenue Next 2Y67.57%
Revenue Next 3Y63.68%
Revenue Next 5Y50.48%

3.3 Evolution

7V0.DE Yearly Revenue VS Estimates7V0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M 250M
7V0.DE Yearly EPS VS Estimates7V0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. 7V0.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 7V0 is valuated cheaply with a Price/Earnings ratio of 6.06.
  • 94.44% of the companies in the same industry are more expensive than 7V0, based on the Price/Earnings ratio.
  • 7V0's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.91.
  • With a Price/Forward Earnings ratio of 181.19, 7V0 can be considered very expensive at the moment.
  • 7V0's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 7V0 is cheaper than 73.61% of the companies in the same industry.
  • 7V0's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 6.06
Fwd PE 181.19
7V0.DE Price Earnings VS Forward Price Earnings7V0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • 7V0's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 7V0 is cheaper than 97.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.65
7V0.DE Per share data7V0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • A cheap valuation may be justified as 7V0's earnings are expected to decrease with -24.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-81.7%
EPS Next 3Y-24.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 7V0.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.36%, 7V0 is a good candidate for dividend investing.
  • In the last 3 months the price of 7V0 has falen by -20.43%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.81, 7V0 pays a better dividend. On top of this 7V0 pays more dividend than 98.61% of the companies listed in the same industry.
  • 7V0's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.36%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
7V0.DE Yearly Dividends per share7V0.DE Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2Y-81.7%
EPS Next 3Y-24.02%
7V0.DE Yearly Income VS Free CF VS Dividend7V0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 20M -20M 40M 60M 80M

More info and screens

Find the best dividend stocksShow peers with best dividend

7V0.DE Fundamentals: All Metrics, Ratios and Statistics

DARWIN AG

FRA:7V0 (4/28/2026, 7:00:00 PM)

9.15

+0.3 (+3.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength40.54
Industry Growth78
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners57.5%
Ins Owner ChangeN/A
Market Cap109.80M
Revenue(TTM)25.29M
Net Income(TTM)18.10M
Analysts83.33
Price Target26.52 (189.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.36%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.06
Fwd PE 181.19
P/S 4.34
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 1.18
EV/EBITDA 0.65
EPS(TTM)1.51
EY16.5%
EPS(NY)0.05
Fwd EY0.55%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.11
BVpS8.61
TBVpS7.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number17.1054 (86.94%)
Profitability
Industry RankSector Rank
ROA 13.36%
ROE 17.51%
ROCE 20.9%
ROIC 14.71%
ROICexc 25.48%
ROICexgc 29.51%
OM 104.25%
PM (TTM) 71.56%
GM 40.86%
FCFM N/A
ROA(3y)10.66%
ROA(5y)N/A
ROE(3y)19.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 0.21
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.48
Quick Ratio 8.1
Altman-Z 4.43
F-ScoreN/A
WACC7.59%
ROIC/WACC1.94
Cap/Depr(3y)119.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45606.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-81.25%
EPS Next 2Y-81.7%
EPS Next 3Y-24.02%
EPS Next 5Y6.23%
Revenue 1Y (TTM)39.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year123.83%
Revenue Next 2Y67.57%
Revenue Next 3Y63.68%
Revenue Next 5Y50.48%
EBIT growth 1Y804.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-111.22%
EBIT Next 3Y-15.97%
EBIT Next 5Y12.57%
FCF growth 1Y-38.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.74%
OCF growth 3YN/A
OCF growth 5YN/A

DARWIN AG / 7V0.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DARWIN AG?

ChartMill assigns a fundamental rating of 5 / 10 to 7V0.DE.


What is the valuation status of DARWIN AG (7V0.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to DARWIN AG (7V0.DE). This can be considered as Fairly Valued.


How profitable is DARWIN AG (7V0.DE) stock?

DARWIN AG (7V0.DE) has a profitability rating of 4 / 10.


What is the financial health of DARWIN AG (7V0.DE) stock?

The financial health rating of DARWIN AG (7V0.DE) is 6 / 10.